<DOC>
	<DOCNO>NCT01222039</DOCNO>
	<brief_summary>The main purpose trial ass safety feasibility treatment two-dose infusion allogeneic mesenchymal stem cell adipose tissue expand vitro patient undergoing haematopoietic stem cell transplantation ( HSCT , develop chronic extensive graft versus host disease ( GVHD ) . Mesenchymal stem cell ( MSCs ) express low level HLA class I molecules , express class II molecules neither CD40 , CD80 CD86 , unable induce proliferation allogeneic lymphocytes . In addition , MSCs inhibit lymphocyte proliferation inhibit cell division maintain cell quiescent state . This support hypothesis MSCs universal suppressor .</brief_summary>
	<brief_title>Multicenter Clinical Trial Evaluation Mesenchymal Stem Cells From Adipose Tissue Patients With Chronic Graft Versus Host Disease .</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Immune System Diseases</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patients develop chronic extensive GVHD determine National Institute Health Consensus Development Project Criteria Clinical Trials Chronic GVHD ( Biol Blood Marrow Transplant 2005 ; 11 : 945955 ) , meet follow criterion : 1 . They never receive therapy chronic GVHD . 2 . They de novo quiescent chronic extend GVHD . 1 . Concomitant severe systemic infection . 2 . Oncologic hematological condition relapse . 3 . Pregnancy . 4 . Estimated life expectancy le 1 week . 5 . Patients give informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Graft versus host disease</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Allogeneic mesenchymal stem cell</keyword>
	<keyword>Adipose tissue</keyword>
	<keyword>Allotransplant</keyword>
	<keyword>Allogenic</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Chronic</keyword>
	<keyword>Expanded</keyword>
</DOC>